» Articles » PMID: 8300201

Cytopathic Effect, Plaque Formation, and Lysis of Ehrlichia Chaffeensis Grown on Continuous Cell Lines

Overview
Journal Infect Immun
Date 1994 Feb 1
PMID 8300201
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Ehrlichiae are strict intracellular bacterial pathogens that parasitize leukocytes or other blood cells. Only six agents of the tribe Ehrlichieae, namely, Cowdria ruminantium, Neorickettsia helminthoeca, Ehrlichia risticii, Ehrlichia sennetsu, Ehrlichia canis, and Ehrlichia chaffeensis, have been adapted to growth in continuous cell lines. E. chaffeensis, the agent of human ehrlichiosis, has been cultured only in a cell line of canine origin. We adapted purified cell-free E. chaffeensis for growth in human embryonic lung (HEL) fibroblasts (HEL 299), green monkey kidney cells (Vero), and a human cervical epithelioid carcinoma (HeLa) cell line. We observed a cytopathic effect with both Vero cells and HEL cells and plaque formation with cellular lysis when infected Vero cells were cultured in agar. Human fibroblasts are already commonly used for the isolation of viruses, coexiellae, and rickettsiae. Furthermore, the capability of these cells to support the growth of ehrlichiae suggests that they may be useful for primary isolation of ehrlichiae as well. The cytopathic effect produced in Vero or HEL cells offers a very helpful indicator of the infection. Plaque formation in Vero cells is a new phenomenon not yet reported for ehrlichiae and will allow the titration of inocula and clonal purification of this bacterium.

Citing Articles

Current and past strategies for bacterial culture in clinical microbiology.

Lagier J, Edouard S, Pagnier I, Mediannikov O, Drancourt M, Raoult D Clin Microbiol Rev. 2015; 28(1):208-36.

PMID: 25567228 PMC: 4284306. DOI: 10.1128/CMR.00110-14.


Survival, replication, and antibody susceptibility of Ehrlichia chaffeensis outside of host cells.

Li J, Winslow G Infect Immun. 2003; 71(8):4229-37.

PMID: 12874298 PMC: 166042. DOI: 10.1128/IAI.71.8.4229-4237.2003.


Ehrlichia chaffeensis: a prototypical emerging pathogen.

Paddock C, Childs J Clin Microbiol Rev. 2003; 16(1):37-64.

PMID: 12525424 PMC: 145301. DOI: 10.1128/CMR.16.1.37-64.2003.


Isolation and characterization of Ehrlichia chaffeensis strains from patients with fatal ehrlichiosis.

Paddock C, Sumner J, Shore G, Bartley D, Elie R, McQuade J J Clin Microbiol. 1997; 35(10):2496-502.

PMID: 9316896 PMC: 229999. DOI: 10.1128/jcm.35.10.2496-2502.1997.


Cultivation of Ehrlichia chaffeensis in mouse embryo, Vero, BGM, and L929 cells and study of Ehrlichia-induced cytopathic effect and plaque formation.

Chen S, Popov V, Feng H, Wen J, Walker D Infect Immun. 1995; 63(2):647-55.

PMID: 7822034 PMC: 173044. DOI: 10.1128/iai.63.2.647-655.1995.


References
1.
McDade J, Stakebake J, Gerone P . Plaque assay system for several species of Rickettsia. J Bacteriol. 1969; 99(3):910-2. PMC: 250118. DOI: 10.1128/jb.99.3.910-912.1969. View

2.
Ehret J, Judson F . Susceptibility testing of Chlamydia trachomatis: from eggs to monoclonal antibodies. Antimicrob Agents Chemother. 1988; 32(9):1295-9. PMC: 175854. DOI: 10.1128/AAC.32.9.1295. View

3.
STEPHENSON E, Osterman J . Canine peritoneal macrophages: cultivation and infection with Ehrlichia canis. Am J Vet Res. 1977; 38(11):1815-9. View

4.
Wellman M, Krakowka S, Jacobs R, Kociba G . A macrophage-monocyte cell line from a dog with malignant histiocytosis. In Vitro Cell Dev Biol. 1988; 24(3):223-9. DOI: 10.1007/BF02623551. View

5.
McDade J . Ehrlichiosis--a disease of animals and humans. J Infect Dis. 1990; 161(4):609-17. DOI: 10.1093/infdis/161.4.609. View